Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism EGFR C797S inhibitors(Epidermal Growth Factor Receptor C797S inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H39ClN8O3S |
InChIKeyOZRNZXPMNJNRPE-UHFFFAOYSA-N |
CAS Registry2349336-18-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | KR | 14 Feb 2022 |